P2 specific lymphocyte transformation in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy.
T lymphocyte activation antigens in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy.
Antibody responses to P0 and P2 myelin proteins in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy.
Peripheral neuropathies.
Hanewinckel R, Ikram MA, Van Doorn PA.
Handb Clin Neurol. 2016;138:263-82. doi: 10.1016/B978-0-12-802973-2.00015-X.
Updated consensus statement: Intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committee.
Tavee J, Brannagan TH 3rd, Lenihan MW, Muppidi S, Kellermeyer L, D Donofrio P; AANEM.
Muscle Nerve. 2023 Oct;68(4):356-374. doi: 10.1002/mus.27922. Epub 2023 Jul 11.
Current Biomarker Strategies in Autoimmune Neuromuscular Diseases.
Oeztuerk M, Henes A, Schroeter CB, Nelke C, Quint P, Theissen L, Meuth SG, Ruck T.
Cells. 2023 Oct 15;12(20):2456. doi: 10.3390/cells12202456.
T lymphocyte activation antigens in Guillain-Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy.
Taylor WA, Hughes RA.
J Neuroimmunol. 1989 Sep;24(1-2):33-9. doi: 10.1016/0165-5728(89)90095-7.
Serum interleukin-2 concentrations in Guillain-Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis.
Hartung HP, Reiners K, Schmidt B, Stoll G, Toyka KV.
Ann Neurol. 1991 Jul;30(1):48-53. doi: 10.1002/ana.410300110.
P2 specific lymphocyte transformation in Guillain-Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy.
Taylor WA, Brostoff SW, Hughes RA.
J Neurol Sci. 1991 Jul;104(1):52-5. doi: 10.1016/0022-510x(91)90215-s.
Subacute idiopathic demyelinating polyradiculoneuropathy.
Hughes R, Sanders E, Hall S, Atkinson P, Colchester A, Payan P.
Arch Neurol. 1992 Jun;49(6):612-6. doi: 10.1001/archneur.1992.00530300044009.
Autoantibodies in neuromuscular disorders: a review of their utility in clinical practice.
Loser V, Vicino A, Théaudin M.
Front Neurol. 2024 Nov 1;15:1495205. doi: 10.3389/fneur.2024.1495205. eCollection 2024.
Antibody responses to P0 and P2 myelin proteins in Guillain-Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy.
Khalili-Shirazi A, Atkinson P, Gregson N, Hughes RA.
J Neuroimmunol. 1993 Jul;46(1-2):245-51. doi: 10.1016/0165-5728(93)90255-w.
[Intravenous immunoglobulin (IVIG)].
Hara M.
Nihon Rinsho. 2009 Mar;67(3):599-605.
